Recent advances in the genetics of primary immunodeficiency syndromes

Journal of Pediatrics

Volumn 129, Issue 1, 1996, Pages 8-24

  Shyur, S D ^a   Hill, H R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PURINE NUCLEOSIDE PHOSPHORYLASE;

AGAMMAGLOBULINEMIA; ATAXIA TELANGIECTASIA; CELL MEDIATED CYTOTOXICITY; CHEDIAK HIGASHI SYNDROME; COMBINED IMMUNODEFICIENCY; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; DIFFERENTIAL DIAGNOSIS; DIGEORGE SYNDROME; ENZYME DEFICIENCY; GENETIC ANALYSIS; HUMAN; IMMUNE DEFICIENCY; PHAGOCYTOSIS; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0029839483     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70184-1     Document Type: Article

References (164)

1. P. Lane Common variable immunodeficiency: does life begin at 40? Clin Exp Immunol 95 1994 201 203
2. B Alarcon JR Regueiro A Arnaiz-Villena Familial defect in the surface expression of the T-cell receptor-CD3 complex N Engl J Med 319 1988 1203 1208
3. ET Chu LJ Rosenwasser CA Dinarello Immunodeficiency with defective T-cell response to interleukin 1 Proc Natl Acad Sci USA 81 1984 4945 4949
4. SG. Raif Antibody deficiency syndromes and novel immunodeficiencies Pediatr Infect Dis J 7 1988 S57 S60
5. K Weinberg R. Parkman Severe combined immunodeficiency due to a specific defect in the production of interleukin-2 N Engl J Med 322 1990 1718 1723
6. JP DiSanto CA Keever TN Small Absence of interleukin-2 production in a severe combined immunodeficiency disease syndrome with T cells J Exp Med 171 1990 1697 1704
7. M Noguchi H Yi HM Rosenblatt Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans Cell 73 1993 147 157
8. T Chatila R Wong M Young An immunodeficiency characterized by defective signal transduction in T lymphocytes N Engl J Med 320 1989 696 702
9. RKB Schuurman JJ Van Rood JM Vossen Failure of lymphocyte-membrane HLA A and B expression in two siblings with combined immunodeficiency Clin Immunol Immunopathol 14 1979 418 434
10. JL Touraine J Betuel G Souillet Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigens J Pediatr 93 1978 47 51
11. C De Preval B Lisowska-Grospierre M Loche A transacting class II regulatory gene linked to the MHC control expression of HLA class II genes Nature 318 1985 291 293
12. LT. Clement The class II major histocompatibility complex antigen deficiency syndrome: consequences of absence of class II major histocompatibility antigens for lymphocyte differentiation and function J Invest Dermatol 94 1990 S118 S121
13. A Durandy C. Griscelli Prenatal diagnosis of severe combined immunodeficiency and X-linked agammaglobulinemia Birth Defects 19 1983 125 127
14. K Blakemore A Scioscia P Grannum The value of fetal blood sampling in the prenatal diagnosis of severe combined immunodeficiency syndrome [abstract] Am J Hum Genet 41 suppl 1987 A267
15. RJ O'Reilly CA Keever TN Small J. Brochstein The use of HLA-nonidentical T cell depleted marrow transplants for correction of SCID Immunodef Rev 1 1989 273 309
16. R Pahwa T Chatila S Pahwa Recombinant interleukin-2 therapy in severe combined immunodeficiency disease Proc Natl Acad Sci USA 86 1989 5069 5073
17. RH Buckley SE Schiff HA Sampson Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation J Immunol 136 1986 2398 2407
18. JW Sleasman TO Harville GB White JF George DJ Barrett MM. Goodenow Arrested rearrangement of TCR Vβ genes in thymocytes from children with X-linked severe combined immunodeficiency disease J Immunol 153 1994 442 448
19. M Kondo T Takeshita N Ishii Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4 Science 262 1993 1874 1877
20. M Noguchi Y Nakamura SM Russel Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor Science 262 1993 1977 1980
21. JM Puck CC Stewart RL. Nussbaum Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency Am J Hum Genet 50 1992 742 748
22. JM Puck RL Nussbaum DL Smead ME. Conley X-linked severe combined immunodeficiency: localization within the region Xq13.1-q21.1 by linkage and deletion analysis Am J Hum Genet 44 1989 724 730
23. JM Puck CM Krauss SM Puck Prenatal test for X-linked severe combined immunodeficiency by analysis of maternal X-chromosome inactivation and linkage analysis N Engl J Med 322 1990 1063 1066
24. J Goodship S Malcolm YL Lau Use of X chromosome inactivation analysis to establish carrier status for X-linked severe combined immunodeficiency Lancet 1 1988 729 732
25. JA Winkelstein E. Fearon Carrier detection of the X-linked primary immunodeficiency diseases using X-chromosome inactivation analysis J Allergy Clin Immunol 85 1990 1090 1097
26. B Schmucker A Meindl H Achatz A PCR based X-chromosome inactivation assay for carrier detection in X-linked immunodeficiencies using differential methylation of the androgen receptor gene Immunodeficiency 5 3 1995 187 192
27. RW Hendriks ZY Chen H Hinds RK Schuurman IW. Craig Carrier detection in X-linked immunodeficiencies. I. A PCR-based X chromosome inactivation assay at the MAOA locus Immunodeficiency 4 1993 209 211
28. R. Hirschhorn Adenosine deaminase deficiency Immunodef Rev 2 1990 175 198
29. R. Hirschhorn Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies Clin Immunol Immunopathol 40 1986 157 165
30. MS Hershfield RH Buckley ML Greenberg Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase N Engl J Med 316 1987 589 596
31. Y Hyodo R Itoh H Kurozumi Immunological and metabolic reconstitution following successful bone marrow transplantation from an HLA-identical sibling in an infant with adenosine deaminase deficiency and severe combined immunodeficiency: partial restoration of purine metabolism Adv Exp Med Biol 253A 1989 543 547
32. RM Blaese KW Culver AD Miller T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years Science 270 1995 475 480
33. - immunodeficient patients Science 270 1995 470 475
34. DB Kohn KI Weinberg JA Nolta Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency Nature Medicine 1 1995 1017 1023
35. + cells in human thymic medulla results in selective immune deficiency J Exp Med 170 1989 2177 2182
36. AC Chan TA Kadlecek ME Elder ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency Science 264 1994 1599 1601
37. + T cells due to ZAP-70 deficiency Cell Immunol 165 1995 110 117
38. BJ Trask H Massa S Kenwrick J. Gitschier Mapping of human chromosome Xq28 by two-color fluorescence in situ hybridization of DNA sequences to interphase cell nuclei Am J Hum Geent 48 1991 1 15
39. EW Gelfand K Weinberg BD Mazer TA Kadlecek A. Weiss Absence of ZAP-70 prevents signaling through the antigen receptor on peripheral blood T cells but not on thymocytes J Exp Med 182 1995 1057 1066
40. ML. Markert Purine nucleoside phosphorylase deficiency Immunodef Rev 3 1991 45 81
41. MD Foresman DM Nelson RS. McIvor Correction of purine nucleoside phosphorylase deficiency by retroviral-mediated gene transfer in mouse S49 T cell lymphoma: a model for gene therapy of T cell immunodeficiency Hum Gene Ther 3 1992 625 631
42. K Savitsky A Bar-Shira S Giland A single ataxia-telangiectasia gene with a product similar to PI-3 kinase Science 268 1995 1749 1753
43. TA. Waldman Immunodeficiency diseases: primary and acquired 4th ed M Samter MM Frank Immunological diseases. 1988 : Little, Brown Boston 411 465
44. S Murphy R. Zwerdling Ataxia telangiectasia: a defect of tissue maturation and DNA repair Cutis 34 1984 433 439
45. VA Oxelius A Izzet Berkel LA. Hanson IgG2 deficiency in ataxia-telangiectasia N Engl J Med 306 1982 515 517
46. DL Nelson WE Biddison S. Shaw Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia telangiectasia J Immunol 130 1983 2629 2634
47. M Carbonari M Cherchi R Paganelli Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia N Engl J Med 322 1990 73 76
48. S. Takai KK Sanford RE. Tarone A procedure for carrier detection in ataxia-telangiectasia Cancer Genet Cytogenet 46 1990 139 140
49. RA Gatti KL Peterson J Novak Prenatal genotyping of ataxia-telangiectasia [letter] Lancet 342 1993 376
50. RA. Gatti Localizing the genes for ataxia-telangiectasia: a human model for inherited cancer susceptibility Adv Cancer Res 56 1991 77 104
51. S Kodama K Komatsu Y Okumura M. Oshimura Suppression of x-ray-induced chromosome aberrations in ataxia telangiectasia cells by introduction of a normal human chromosome 11 Mutat Res 293 1992 31 37
52. G De Saint-Basile B Arveiler NJ Fraser Close linkage of hypervariable marker DXS255 to the disease locus of Wiskott-Aldrich syndrome Lancet 2 1989 1319 1320
53. WL Greer MM Mahtani PC Kwong Linkage studies of the Wiskott-Aldrich syndrome: polymorphisms at TIMP and the X chromosome centromere are informative markers for genetic prediction Hum Genet 83 1989 227 230
54. WL Greer E Higgins DR Sutherland Altered expression of leukocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in 0-glycosylation Biochem Cell Biol 67 1989 503 509
55. JMJ Derry HD Ochs U. Francke Isolation of a novel gene mutated in Wiskott-Aldrich syndrome Cell 78 1994 635 664
56. Y Boyd NJ. Fraser Methylation patterns at the hypervariable X-chromosome locus DXS255 (M27β): correlation with X-inactivation status Genomics 7 1990 182 187
57. M Schwartz RS Mibashan KH. Nicolaides First-trimester diagnosis of Wiskott-Aldrich syndrome by DNA markers [letter] Lancet 2 1989 1405
58. SL Rumelhart ME Trigg SD Horwitz Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome Blood 75 1990 1031 1035
59. EJ Lammer JM. Opitz The DiGeorge anomaly as a developmental field defect Am J Med Genet suppl 2 1986 113 127
60. A Levy-Mozziconacci F Wernert P Scambler Clinical and molecular study of DiGeorge sequence Eur J Pediatr 153 1994 813 820
61. RA Thomas BH Landing TR. Wells Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge anomaly Am J Med Genet suppl 3 1987 43 66
62. O Sieber BG Durie BG Hattler Spontaneous evolution of immune competence in DiGeorge syndrome [abstract] Pediatr Res 8 1974 144
63. F. Greenberg Hypoparathyroidism and the DiGeorge syndrome N Engl J Med 320 1989 1146 1147
64. DA Driscoll ML Budarf BS. Emanuel Antenatal diagnosis of DiGeorge syndrome Lancet 338 1991 1390 1391
65. CS August RH Levey AI Berkel Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus Lancet 1 1970 1080 1083
66. WW Cleveland BJ Fogel WT Brown Fetal thymic transplant in a case of DiGeorge's syndrome Lancet 2 1968 1211 1214
67. YH Thong EF Robertson HG Rischbieth Successful restoration of immunity in the DiGeorge syndrome with a fetal thymic epithelial transplant Arch Dis Child 53 1978 580 584
68. RW Steele C Limas GB Thurman Familial thymic aplasia: attempted reconstitution with fetal thymus in a millipore diffusion chamber N Eng J Med 287 1972 787 791
69. AB Goldsobel A Haas ER. Stiehm Bone marrow transplantation in DiGeorge syndrome J Pediatr 111 1987 40 44
70. MS Borzy D Ridgway FJ Noya Successful bone marrow transplantation with split lymphoid chimerism in DiGeorge syndrome J Clin Immunol 9 1989 386 392
71. RJ. Wedgwood X-linked agammaglobulinemia D Seligson CRC handbook series in clinical laboratory science; section F vol 1, part 1 1978 : CRC Press West Palm Beach (FL) 41 50
72. S Malcolm G De Saint Basile B Arveiler Close linkage of random DNA fragments from Xq21.3-22 to X-linked agammaglobulinemia (XLA) Hum Genet 77 1987 172 174
73. S Guioli B Arveiler B Bardoni Close linkage of probe p212 (DXS178) to X-linked agammaglobulinemia Hum Genet 84 1989 19 21
74. D Vetrie I Vorechovsky P Sideras The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases Nature 361 1993 226 233
75. S Tsukada DC Saffran DJ Rawlings Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia Cell 72 1993 279 290
76. MD Cooper RH. Buckley Developmental immunology and the immunodeficiency diseases JAMA 248 1982 2658 2669
77. PJ Mease HD Ochs RJ. Wedgwood Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia N Engl J Med 304 1981 1278 1281
78. JB Cooper WR Pratt BK English Coxsackievirus B3 producing fetal meningoencephalitis in a patient with X-linked agammaglobulinemia Arch Pediatr Adolesc Med [Am J Dis Child] 137 1983 82 83
79. PF Wright MH Hatch AG Kasselberg Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia J Pediatr 91 1977 408 412
80. HM Lederman JA. Winkelstein X-linked agammaglobulinemia: an analysis of 96 patients Medicine 64 1985 145 156
81. FS Rosen CA. Janeway The gamma globulins. III. The antibody deficiency syndromes N Engl J Med 275 1966 709 715
82. U Korthauer D Graf HW Mages Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM Nature 361 1993 539 541
83. JP DiSanto JY Bonnefoy JF Gauchat CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM Nature 361 1993 541 543
84. A Aruffo M Farrington D Hollenbaugh The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome Cell 72 1993 291 300
85. RC Allen RJ Armitage ME Conley CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome Science 259 1993 990 993
86. LN Notarangelo M Duse AG. Ugazio Immunodeficiency with hyper IgM (HIM) Immunodef Rev 3 1992 101 121
87. AS Goldman SE Ritzmann EW Houston Dysgammaglobulinemia antibody deficiency syndrome: increased IgM-globulins and decreased IgG- and IgA-globulins J Pediatr 70 1967 16 27
88. RS Geha N Hyslop S Alami F Farah EE Schneeberger FS. Rosen Hyper-immunoglobulin M immunodeficiency (dysgammaglobulinemia) J Clin Invest 64 1979 385 391
89. LD Notarangelo O Parolini A Albertini Analysis of X-chromosome inactivation in X-linked immunodeficiency with hyper-IgM (HIGM1): evidence for involvement of different hematopoietic cell lineages Hum Genet 3 1991 195 236
90. JP DiSanto S Markiewicz JF Gauchat JY Bonnefoy A Fischer G. de Saint Basile Brief report: prenatal diagnosis of X-linked hyper-IgM syndrome N Engl J Med 330 1994 969 973
91. GR Burgio AG Ugazio LD Notarangelo M. Duse The lesson of agammaglobulinemia 40 years after Bruton's discovery Ann Allergy 71 1993 408 415
92. C Ropars A Muller N Paint Large scale detection of IgA-deficient blood donors J Immunol Methods 54 1982 183 189
93. J Mastecky MW Russel S Jackson The human IgA system: a reassessment Clin Immunol Immunopathol 40 1986 105 114
94. L Hammarstrom B Carlsson CI Smith J Wallin L. Wislander Detection of IgA heavy chain constant region genes in IgA deficient donors: evidence against gene deletions Clin Exp Immunol 60 1985 661 664
95. MAH French RL. Dawkins Central MHC genes, IgA deficiency and autoimmune disease Immunol Today 11 1990 271 274
96. FM Schaffer J Palermos ZB Zhu BO Barger MD Cooper JE. Volanakis Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes Proc Natl Acad Sci USA 86 1989 8015 8019
97. O Olerup CIE Smith L. Hammarstrom Different amino acids at position 57 of the HLA-DQ β chain associated with susceptibility and resistance to IgA deficiency Nature 347 1990 289 290
98. PG Olsson L Hammarstrom DW Cox CIE. Smith Involvement of both HLA and Ig heavy chain haplotypes in human IgA deficiency Immunogenetics 36 1992 389 395
99. A Plebani AG Ugazio V Monafo Clinical heterogeneity and reversibility of selective immunoglobulin A deficiency in 80 children Lancet 1 1986 829 831
100. RA Wood HA. Sampson The child with frequent infections Curr Probl Pediatr May 1989 231 284
101. CC. Rundles Clinical and immunologic analyses of 103 patients with common variable immunodeficiency J Clin Immunol 9 1989 22 23
102. FM Schaffer J Palermos ZB Zhu BO Barger MD Cooper JE. Volanakis Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes Proc Natl Acad Sci USA 86 1989 8015 8019
103. RF Ashman FM Schaffer JD Kemp Genetic and immunologic analysis of a family containing five patients with common-variable immune deficiency or selective IgA deficiency J Clin Immunol 12 1992 406 414
104. JE Volanakis Z-B Zhu FM Schaffer Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency J Clin Invest 89 1992 1914 1922
105. JA Rump A Jahreis M Schlesier R Drager I Melchers HH. Peter Possible role of IL-2 deficiency for hypogammaglobulinemia in patients with common variable immunodeficiency Clin Exp Immunol 89 1992 204 210
106. I Tsuge H Matsuoka T Abe Y Kamachi S. Torii X chromosome inactivation analysis to distinguish sporadic cases of X-linked agammaglobulinemia from common variable immunodeficiency Eur J Pediatr 152 1993 900 904
107. C Cunningham-Rundles K Kazbay J Hassett Z Zhou L. Mayer Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol conjugated interleukin-2 N Engl J Med 331 1994 918 921
108. S Zielen P Bauscher D Hofmann SC. Meuer Interleukin-10 and immune restoration in common variable immunodeficiency Lancet 342 1993 750 751
109. WB White M. Ballow Modulation of suppressor-cell activity by cimetidine in patients with common variable hypoglobulinemia N Engl J Med 321 1985 198 202
110. A Fischer B Lisowska-Grospierre DC Anderson Leukocyte adhesion deficiency: molecular basis and functional consequences Immunodef Rev 1 1988 39 54
111. TK Kishmoto TM Robert DC Anderson Cloning of the subunit of LFA-1, Mac-1 and p150,95: homology to a fibronectin receptor and the molecular basis of leukocyte adhesion deficiency [abstract] Fed Proc 46 1987 446
112. MA. Arnaout Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response Immunol Rev 114 1990 145 180
113. DC Anderson FC Schmalstieg MJ Finegold The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features J Infect Dis 152 1985 668 689
114. A Fischer B Lisowska-Grospierre DC Anderson Leukocyte adhesion deficiency: molecular basis and functional consequences Immunodef Rev 1 1988 39 54
115. RF Todd III DR. Freyer The CD11/CD18 leukocyte glycoprotein deficiency Hematol Oncol Clin North Am 2 1 1988 13 31
116. SJ Weisman MJ Mahoney DC Anderson Prenatal diagnosis for Mo1 (CDw18) deficiency [abstract] Clin Res 35 1987 435A
117. TJ Bowen HD Ochs LC Altman Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein J Pediatr 101 1982 932 940
118. A Fischer PH Trung B Descamps-Latscha Bone-marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis, and oxidative response during opsonized particle phagocytosis Lancet 2 1983 473 476
119. F Le-Deist S Blanche H Keable Successful HLA nonidentical bone marrow transplantation in three patients with the leukocyte adhesion deficiency Blood 74 1989 512 516
120. A Back W Kwok M Adam Retroviral-mediated gene transfer of the leukocytes integrin CD18 subunit Biochem Biophys Res Commun 171 1990 787 795
121. JA Wilson AJ Ping JC Krauss Correction of CD18-deficient lymphocytes by retroviral-mediated gene therapy Science 248 1990 1413 1416
122. SM Holland JI. Gallin Neutrophil disorders 5th ed MM Frank KF Austen HN Claman ER Unanue Samter's immunologic diseases. 1995 : Little, Brown Boston 529 550
123. LA Boxer JE. Smolen Neutrophil granule constituents and their release in health and disease Hematol Oncol Clin North Am 2 1988 101 134
124. PE Weary AS. Bender Chédiak-Higashi syndrome with severe cutaneous involvement Arch Intern Med 119 1987 381 386
125. CM Rubin BA Burke RW McKenna The accelerated phase of Chédiak-Higashi syndrome: an expression of the virus-associated hemophagocytic syndrome? Cancer 56 1985 524 530
126. R Diukman S Tanigawara MJ Cowan MS. Golbus Prenatal diagnosis of Chédiak-Higashi syndrome Prenatal diagnosis 12 1992 877 885
127. LA Boxer DF Aibertini RL Baehner Impaired microtubular assembly and polymorphonuclear leukocyte function in the Chédiak-Higashi syndrome correctable by ascorbic acid Br J Haematol 43 1976 207 213
128. RS Weening D Schoorel ML Roos Effects of ascorbate on abnormal neutrophil, platelet, and lymphocyte function in a patient with the Chédiak-Higashi syndrome Blood 57 1981 856 864
129. C Griscelli JL. Virelizier Bone marrow transplantation in a patient with Chédiak-Higashi syndrome Birth Defects 19 1983 333 334
130. A Fischer W Friedrick R Levinsky Bone marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985 Lancet 2 1986 1080 1084
131. HA Harfi SA. Malik Chédiak-Higashi syndrome: clinical, hematologic, and immunologic improvement after splenectomy Ann Allergy 69 1992 147 150
132. RM Smith JT. Curnutte Molecular basis of chronic granulomatous disease Blood 77 1991 673 686
133. B Royer-Pokora LM Kunkel AP Monaco Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location Nature 322 1986 32 38
134. MC Dinauer SH. Orkin Molecular genetics of chronic granulomatous disease Hematol Oncol Clin North Am 2 2 1988 225 240
135. MC Dinauer EA Pierce GAP Bruns JT Curnutte SH. Orkin Human neutrophil cytochrome b light chain (p22-phox): gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease J Clin Invest 86 1990 1729 1737
136. RA Clark HL Malech JI Gallin Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cystolic components of the NADPH oxidase system N Engl J Med 321 1989 647 652
137. KJ Lomax TL Leto H Nunoi JI Gallin HL. Malech Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease Science 245 1989 409 414
138. B Volpp WM Nauseef JE Donelson DR Moser RA. Clark Cloning of the cDNA and functional expression of the 47-kilodalton cystolic component of human neutrophil respiratory burst oxidase Proc Natl Acad Sci USA 86 1989 7195 7199
139. c-src Science 248 1990 727 731
140. T Ariga Y Sakiyama H Furuta S. Matsumoto Molecular genetic studies of two families with X-linked chronic granulomatous disease: mutation analysis and definitive determination of carrier status in patient's sisters Eur J Haematol 52 1994 99 102
141. MC Dinauer SH. Orkin Molecular genetics of chronic granulomatous disease Immunodef Rev 1 1988 55 69
142. RAB Ezekowitz JI. Gallin Clinical efficacy of recombinant human interferon-gamma (rIFN-γ) in chronic granulomatous disease (CGD). International Collaborative Study Group to Assess the Efficacy of rIFN-γ in CGD [abstract] Clin Res 38 1990 465A
143. The international chronic granulomatous disease cooperative study group: a controlled trial of interferon gamma to prevent infection in chronic granulomatous disease N Engl J Med 324 1991 509 516
144. JT Curnutte BM. Babior Chronic granulomatous disease Adv Hum Genet 16 1987 229 297
145. JR Hobbs M Monteil DR McCluskey E Jurges M. ElTumi Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor Eur J Pediatr 151 1992 806 810
146. AJ Thrasher M de Alwis CM Casimir Functional reconstitution of the NADPH-oxidase by adeno-associated virus gene transfer Blood 86 1995 761 765
147. + peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b -558 defective forms of chronic granulomatous disease Blood 84 1994 53 58
148. RI Rynes AFH Britten RJ. Pickering Deficiency of the second complement component: association with the HLA haplotype A10, B18 in a normal population Ann Rheum Dis 41 1982 93 96
149. V. Agnello Association of systemic lupus erythematosus and SLE-like syndrome with hereditary and acquired complement deficiency states Arthritis Rheum 21 1978 S146 S152
150. LC. Guenther Inherited disorders of complement Am Acad Dermtol 9 1983 815 839
151. K Steinsson K Erlendsson H. Valdimarsson Successful plasma infusion treatment of a patient with C2 deficiency and systemic lupus erythromatosus: clinical experience over 45 months Arthritis Rheum 32 1989 906 913
152. PH Lehner KA Davies MJ Walport Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release Lancet 340 1992 1379 1381
153. SC Ross P. Denson Complement deficiency states and infection: epidemiology, pathogenesis, and consequences of neisserial and other infections in an immune deficiency Medicine (Baltimore) 63 1984 243 273
154. S Inai Y Akagaki T Moriyama Inherited deficiencies of the late-acting complement components other than C9 found among healthy blood donors Int Arch Allergy Appl Immunol 90 1989 274 279
155. A Gianella-Borradori L Borradori PM Schneider Combined complete C5 and partial C4 deficiency in humans: clinical consequences and complement-mediated functions in vitro Clin Immunol Immunopathol 55 1 1990 41 55
156. LF Fries JJ O'Shea MM. Frank Inherited deficiencies of complement and complement-related proteins Clin Immunol Immunopathol 40 1986 37 49
157. MS Edwards CJ. Baker Complications and sequelae of meningococcal infections in children J Pediatr 99 1981 540 545
158. RT Ellison PF Kohler JF Curd Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease N Engl J Med 308 1983 913 916
159. D Goundis SM Holt Y Boyd Localization of the properdin structural locus to Xp11.23-Xp21.1 Genomic 5 1989 56 60
160. SD Shyur HR. Hill Immunodeficiency in the 1990s Pediatr Infect Dis J 10 1991 595 611
161. JM. Puck Molecular and genetic basis of X-linked immunodeficiency disorders J Clin Immunol 14 1994 81 89
162. A Durandy Y Dumez D Guy-Grand Prenatal diagnosis of severe combined immunodeficiency J Pediatr 101 1982 995 997
163. YL Law RJ. Levensky Prenatal diagnosis and carrier detection in primary immunodeficiency disorders Arch Dis Child 68 1988 758 764
164. JM. Puck Prenatal diagnosis and genetic analysis of X-linked immunodeficiency disorders Pediatr Res 33 1992 S29 S34